Liraglutide research: the daily GLP-1 agonist
Liraglutide research: how this daily GLP-1 receptor agonist (predecessor of semaglutide) was studied in relation to glucose and weight. RUO.
Can't find your peptide? Can't find your peptide?
💬 WhatsAppLiraglutide research: how this daily GLP-1 receptor agonist (predecessor of semaglutide) was studied in relation to glucose and weight. RUO.
Lipotropic substances research: how Lipo-C, MIC+B12 and L-carnitine are studied in the context of fat metabolism and lipolysis. RUO.
KPV research: how this tripeptide (α-MSH fragment) is studied in relation to inflammation and gut/skin models. RUO.
Ipamorelin vs CJC-1295 vs sermorelin: differences in mechanism, half-life and selectivity between ghrelin agonist and GHRH analogues. RUO.
Immune System Peptides Under Investigation: Thymosin Alpha-1, Thymalin, VIP, LL-37, and KPV, and How They Modulate Immune Response in Studies. RUO.
IGF-1 LR3 research: how this long-acting IGF-1 analogue influences cell proliferation and muscle growth via IGF-1R in studies. RUO.
Skin and tanning peptides in research: Melanotan 1 & 2, SNAP-8, GHK-Cu and AHK-Cu, and how they are studied for pigment, collagen and skin in research. RUO.
HGH Fragment 176-191 research: how this C-terminal growth-hormone fragment is studied for lipolysis and fat metabolism in research. RUO.
Hexarelin research: how this hexapeptide ghrelin agonist influences GH release and the CD36 pathway in studies. RUO.
Gonadorelin research: how this synthetic GnRH drives LH and FSH release and the reproductive axis in studies. RUO.
Peplife sells exclusively to qualified researchers aged 18 and over.